Literature DB >> 25664786

Structure of the apo anti-influenza CH65 Fab.

Peter S Lee1, Ashley J Arnell1, Ian A Wilson1.   

Abstract

Influenza viruses remain a persistent challenge to human health owing to their inherent ability to evade the immune response by antigenic drift. However, the discovery of broadly neutralizing antibodies (bnAbs) against divergent viruses has sparked renewed interest in a universal influenza vaccine and novel therapeutic opportunities. Here, a crystal structure at 1.70 Å resolution is presented of the Fab of the human antibody CH65, which has broad neutralizing activity against a range of seasonal H1 isolates. Previous studies proposed that affinity maturation of this antibody lineage pre-organizes the complementarity-determining region (CDR) loops into an energetically favorable HA-bound conformation. Indeed, from the structural comparisons of free and HA-bound CH65 presented here, the CDR loops, and in particular the heavy-chain CDR3, adopt the same conformations in the free and bound forms. Thus, these findings support the notion that affinity maturation of the CH65 lineage favorably preconfigures the CDR loops for high-affinity binding to influenza hemagglutinin.

Entities:  

Keywords:  adaptive immunity; affinity maturation; antibody; influenza

Mesh:

Substances:

Year:  2015        PMID: 25664786      PMCID: PMC4321466          DOI: 10.1107/S2053230X14027599

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  20 in total

1.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

2.  A systematic comparison of free and bound antibodies reveals binding-related conformational changes.

Authors:  Inbal Sela-Culang; Shahar Alon; Yanay Ofran
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

3.  Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.

Authors:  Peter S Lee; Nobuko Ohshima; Robyn L Stanfield; Wenli Yu; Yoshitaka Iba; Yoshinobu Okuno; Yoshikazu Kurosawa; Ian A Wilson
Journal:  Nat Commun       Date:  2014-04-10       Impact factor: 14.919

4.  Rapid development of broadly influenza neutralizing antibodies through redundant mutations.

Authors:  Leontios Pappas; Mathilde Foglierini; Luca Piccoli; Nicole L Kallewaard; Filippo Turrini; Chiara Silacci; Blanca Fernandez-Rodriguez; Gloria Agatic; Isabella Giacchetto-Sasselli; Gabriele Pellicciotta; Federica Sallusto; Qing Zhu; Elisa Vicenzi; Davide Corti; Antonio Lanzavecchia
Journal:  Nature       Date:  2014-10-05       Impact factor: 49.962

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.

Authors:  Aaron G Schmidt; Huafeng Xu; Amir R Khan; Timothy O'Donnell; Surender Khurana; Lisa R King; Jody Manischewitz; Hana Golding; Pirada Suphaphiphat; Andrea Carfi; Ethan C Settembre; Philip R Dormitzer; Thomas B Kepler; Ruijun Zhang; M Anthony Moody; Barton F Haynes; Hua-Xin Liao; David E Shaw; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-21       Impact factor: 11.205

7.  Multi-constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility.

Authors:  Mariana Babor; Tanja Kortemme
Journal:  Proteins       Date:  2009-06

8.  Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.

Authors:  Yuval Avnir; Aimee S Tallarico; Quan Zhu; Andrew S Bennett; Gene Connelly; Jared Sheehan; Jianhua Sui; Amr Fahmy; Chiung-yu Huang; Greg Cadwell; Laurie A Bankston; Andrew T McGuire; Leonidas Stamatatos; Gerhard Wagner; Robert C Liddington; Wayne A Marasco
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

Review 1.  Structure-Based Vaccine Antigen Design.

Authors:  Barney S Graham; Morgan S A Gilman; Jason S McLellan
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.